News

Researchers at BC Cancer Research Institute, led by Dr. Bernie Eigl, director of the Provincial Clinical Trials Office, and Dr. Alex Wyatt, senior scientist and scientific director of the Cancer Genetics and Genomics Laboratory, examined whether a blood test that analyzes cancer-derived DNA found in the blood, called circulating tumour DNA (ctDNA), could help identify more patients with metastatic urothelial carcinoma – an aggressive form of bladder cancer – who are eligible for FGFR-targeted therapy.

The International Society for Stem Cell Research (ISSCR) has named Dr. Allen Eaves and the late Dr. Connie Eaves as recipients of the 2026 ISSCR Lifetime Achievement Award, recognizing their transformative contributions to stem cell science, leukemia research, mentorship and the global biotechnology ecosystem.

Today, the Honourable Marjorie Michel, Minister of Health, announced that the Government of Canada and partners are investing over $41 million in groundbreaking cancer prevention research.

An international collaboration involving BC researchers has been awarded $2 million to use AI to identify factors tied to long-term survival.

Dr. Ali Bashashati, lead Canadian researcher on the Global Ovarian Cancer Research Consortium AI Accelerator Grant, is advancing the use of artificial intelligence to improve prediction and treatment for ovarian cancer.

A prevention strategy developed by BC researchers reduces the risk of the most common and deadly form of ovarian cancer by nearly 80 per cent, according to a new UBC study published today in JAMA Network Open.

A new study led by BC Cancer researchers shows that classic Hodgkin lymphoma (CHL) is not one disease, but several biologically distinct subtypes.